Financial statements Bioleaf Pharma
Balance sheet of Bioleaf Pharma
Company age:
Age:
19 y. 2 m.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of BIOLEAF PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 101 926,81 | 1 113 146,33 | 1 113 203,41 | 1 105 393,17 | 1 058 770,69 | 1 058 864,09 |
| A. Fixed assets | 791 796,45 | 791 596,45 | 791 396,45 | 737 500,00 | 737 500,00 | 737 500,00 |
| B. Current assets | 310 130,36 | 321 549,88 | 321 806,96 | 367 893,17 | 321 270,69 | 321 364,09 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 101 926,81 | 1 113 146,33 | 1 113 203,41 | 1 105 393,17 | 1 058 770,69 | 1 058 864,09 |
| A. Equity | 1 099 424,05 | 1 109 093,77 | 1 107 573,25 | 1 099 763,01 | 1 053 140,53 | 1 051 858,93 |
| B. Liabilities and provisions for liabilities | 2 502,76 | 4 052,56 | 5 630,16 | 5 630,16 | 5 630,16 | 7 005,16 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.